Companies / Japan
Pfizer, Astellas Launch Rival Bladder Drugs
June 2006 | Product LaunchUS drug major Pfizer and Japanese major Astellas are launching rival therapies for hyperactive bladder in Japan. The US firm's Detrusitol will be priced at JPY204.3 (US$1.78) per 4mg capsule under the NHI national health insurance scheme.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
